Dr. Shane Klingonsmith

D.M.D | Dentist



  
  4555 Easton Ave, Bethlehem
  Pennsylvania, 18020-9343

  610-866-0552    Maps & Directions
Dr. Shane Klingonsmith is a Bethlehem, Pennsylvania based Dentist who is specialized in General Practice Dentistry. He may accept the Medicare-approved amount. Patients may be billed for more than the Medicare deductible and coinsurance. His current practice location is 4555 Easton Ave, Bethlehem. Patients can reach him at 610-866-0552.
Dr. Shane Klingonsmith is the primary dental care provider for patients of all ages. He is responsible for the diagnosis, treatment, management and overall coordination of services related to patients' oral health needs.
Complete Profile:
Dr. Shane Klingonsmith speciality, credentials, practice address, contact phone number and fax are as below. Patients can directly walk in or can call on the below given phone number for appointment.
Name: Dr. Shane Klingonsmith
Specialization: Dentist
Gender:Male
Credentials: D.M.D
Accepts Medicare Assignment:May Accept
Practice Address:4555 Easton Ave, Bethlehem,
Pennsylvania, 18020-9343
Phone:610-866-0552
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS). NPI details are as mentioned below.
PAC ID: 8325332679
Enrollment ID: I20160809001231
NPI Number: 1205910767
NPI Enumeration Date: 24 Oct, 2006
NPI Last Update On: 28 Jan, 2013

Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address: 4555 Easton Ave,
Bethlehem, Pennsylvania
Zip: 18020-9343
Phone Number: 610-866-0552
Patients can reach Dr. Shane Klingonsmith at 4555 Easton Ave, Bethlehem, Pennsylvania or can call to book an appointment on 610-866-0552. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 09 December, 2024.

Comments/ Reviews: